Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypotension
Evaluation of Inferior Vena Cava and Femoral Vein Collapsibility Indices for Predicting Post-Spinal Hypotension in Patients Undergoing Transurethral Prostate Resection: A Prospective Observational Study
1 other identifier
observational
110
1 country
1
Brief Summary
Spinal anesthesia is commonly used in transurethral prostate resection (TUR-P) surgeries; however, post-spinal hypotension remains a frequent and clinically significant complication, particularly in elderly patients. Early prediction of hypotension may allow timely interventions and improve patient safety. This prospective observational study aims to evaluate the predictive value of preoperative ultrasound-based inferior vena cava collapsibility index (IVC-CI) and femoral vein collapsibility index (FVCI) for post-spinal hypotension in patients undergoing elective TUR-P under spinal anesthesia. Before spinal anesthesia, IVC and femoral vein measurements will be obtained using ultrasonography. Hemodynamic parameters will be recorded before and after spinal anesthesia, and the occurrence of hypotension will be assessed according to predefined criteria. The study seeks to compare the diagnostic performance of IVC-CI and FVCI in predicting post-spinal hypotension and to identify potential clinical predictors associated with hypotension in this patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
CompletedMarch 27, 2026
March 1, 2026
3 months
March 23, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of Post-Spinal Hypotension Using Inferior Vena Cava and Femoral Vein Collapsibility Indices
The primary outcome is the predictive value of the inferior vena cava collapsibility index (IVC-CI) and femoral vein collapsibility index (FVCI) for the development of post-spinal hypotension. Hypotension is defined as a systolic blood pressure \<90 mmHg, a decrease in systolic blood pressure \>30% from baseline, or a mean arterial pressure \<60 mmHg within 15 minutes after spinal anesthesia.
Within the first 15 minutes after spinal anesthesia
Secondary Outcomes (1)
Comparison of Diagnostic Performance of IVC-CI and FVCI for Post-Spinal Hypotension
Within the first 15 minutes after spinal anesthesia
Study Arms (2)
Post-Spinal Hypotension Group
Patients who develop hypotension after spinal anesthesia according to predefined hemodynamic criteria.
Non-Hypotension Group
Patients who do not develop hypotension following spinal anesthesia.
Eligibility Criteria
The study population consists of adult male patients aged 18-75 years with American Society of Anesthesiologists (ASA) physical status I-III who are scheduled to undergo elective transurethral resection of the prostate (TUR-P) under spinal anesthesia. All participants will be recruited from a single tertiary care center. Patients will be evaluated preoperatively, and eligible individuals who provide written informed consent will be included in the study.
You may qualify if:
- Adult patients aged 18-75 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for elective transurethral resection of the prostate (TUR-P)
- Planned spinal anesthesia
- Ability to provide written informed consent
You may not qualify if:
- Refusal to participate in the study
- Body mass index (BMI) \>30 kg/m²
- Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
- Emergency surgery
- Baseline systolic arterial blood pressure \<90 mmHg or mean arterial pressure \<70 mmHg
- Major peripheral vascular disease or severe cardiovascular disease
- Unstable angina or left ventricular ejection fraction \<40%
- Chronic respiratory disease
- Increased intra-abdominal pressure
- Autonomic nervous system disorders
- Implanted pacemaker or implantable cardioverter-defibrillator
- Anticipated difficult airway
- Cognitive impairment or inability to cooperate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences, Antalya Training and Research Hospital
Antalya, Muratpasa, 07030, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Kerem Inanoglu, Medical Doctor
University of Health Sciences, Antalya Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start
January 1, 2026
Primary Completion
April 15, 2026
Study Completion
May 30, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03